263050 — Eutilex Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Eutilex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,036	73.5	216	132	9,527
Cost of Revenue
Gross Profit	—	—	—	—	625
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	26,925	33,633	34,367	29,835	39,366
Operating Profit	-24,888	-33,560	-34,151	-29,703	-29,839
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-28,768	-29,575	-34,470	-28,342	-29,558
Provision for Income Taxes
Net Income After Taxes	-28,768	-29,575	-34,470	-28,342	-29,499
Minority Interest
Net Income Before Extraordinary Items
Net Income	-28,768	-29,893	-33,427	-27,718	-29,166
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-28,768	-29,893	-33,427	-27,718	-29,166
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,099	-1,110	-1,188	-756	-734
Dividends per Share